Clinical Trial Update: ECLAXIR:Search for an Association Between CX3CR1 V249I Polymorphism, Preeclampsia and Endothelial Injury

View source ↗

Summary

The update summarizes results from the ECLAXIR study evaluating whether the CX3CR1 V249I polymorphism is linked to preeclampsia and endothelial injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Preeclampsia | Status: COMPLETED